Youcare Pharmaceutical Group Co., Ltd. (688658.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 12.57

From 52W high−23.29%

Volume12.26M

Market capCNY 5.95B

P/E (TTM)−22.7x

P/S (TTM)2.4x

Div yield—

Key dataSep 18, 2026

Open

CNY 12.57

From 52W high

−23.29%

Volume

12.26M

Market cap

CNY 5.95B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−192.3x

P/E (TTM)

−22.7x

RSI (14)

46.7

MomentumView details →

1D Return

−7.69%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−22.7x

EV/EBITDA

−192.3x

EV/Sales

2.3x

P/S (TTM)

2.4x

P/B (TTM)

1.9x

ProfitabilityView details →

Gross Margin

53.03%

Net Margin

−10.15%

EBITDA Margin

−1.18%

ROE (TTM)

−7.50%

ROA (TTM)

−4.75%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

−28.48%

EPS YoY

—

FCF YoY

+318.74%

Revenue CAGR 3Y

−18.64%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−7.69%

YTD Return

—

1Y Return

—

RSI (14)

46.7

vs 50D SMA

−2.39%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.17x

Current Ratio

1.97x

Quick Ratio

1.60x

Div Yield

—

Div Rate

—

Div Growth 1Y

−81.82%

EarningsView details →

EPS (Actual)

−CNY 0.16

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.42B

Net Income (TTM)

−246.22M

Op. CF (TTM)

303.72M

Latest newsMore news →

Yuekang Pharmaceutical announced it will invest 45 million yuan of excess raised funds into a small nucleic acid drug R&D project, covering three investigational drugs.31d ago

Yuekang Pharmaceutical announced its first-half 2026 results, reporting a net loss attributable to shareholders of 105 million yuan, compared with a loss of 98.8291 million yuan in the same period last year.31d ago

Similar companies

Mirum Pharmaceuticals, Inc.MIRM Travere Therapeutics, Inc.TVTX Liquidia CorporationLQDA Kiniksa Pharmaceuticals, Ltd.KNSA 科前生物688526.SH Terns Pharmaceuticals, Inc.TERN Find similar companies →

Latest newsMore news →

Yuekang Pharmaceutical announced it will invest 45 million yuan of excess raised funds into a small nucleic acid drug R&D project, covering three investigational drugs.31d ago Yuekang Pharmaceutical announced its first-half 2026 results, reporting a net loss attributable to shareholders of 105 million yuan, compared with a loss of 98.8291 million yuan in the same period last year.31d ago